Is Aristo Bio-Tech overvalued or undervalued?

Jun 17 2025 08:03 AM IST
share
Share Via
As of June 16, 2025, Aristo Bio-Tech is considered overvalued with a valuation grade of expensive, a PE ratio of 18.44, and a year-to-date stock decline of 17.29%, lagging behind the Sensex's gain of 5.51%.
As of 16 June 2025, the valuation grade for Aristo Bio-Tech has moved from very expensive to expensive, indicating a slight improvement in its perceived value. The company is currently considered overvalued. Key ratios include a PE ratio of 18.44, an EV to EBITDA of 10.26, and a PEG ratio of 4.50, which suggest that the stock is trading at a premium compared to its earnings growth potential.

In comparison to peers, Aristo Bio-Tech's PE ratio is significantly lower than that of P I Industries, which stands at 37.92, and Bayer CropScience at 43.59, both classified as very expensive. Additionally, while UPL is rated attractive with a PE of 38.78, Aristo's valuation appears less favorable. The company's recent stock performance has lagged behind the Sensex, with a year-to-date decline of 17.29% compared to the Sensex's gain of 5.51%, reinforcing the notion that Aristo Bio-Tech may be overvalued in the current market context.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Aristo Bio-Tech falling/rising?
Nov 22 2025 01:28 AM IST
share
Share Via
How has been the historical performance of Aristo Bio-Tech?
Nov 15 2025 12:27 AM IST
share
Share Via
Why is Aristo Bio-Tech falling/rising?
Oct 29 2025 01:57 AM IST
share
Share Via
Why is Aristo Bio-Tech falling/rising?
Sep 30 2025 11:29 PM IST
share
Share Via
Why is Aristo Bio-Tech falling/rising?
Sep 29 2025 11:38 PM IST
share
Share Via
Why is Aristo Bio-Tech falling/rising?
Sep 24 2025 11:32 PM IST
share
Share Via
Is Aristo Bio-Tech overvalued or undervalued?
Sep 24 2025 08:08 AM IST
share
Share Via